Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Neurogene Inc shares valued at $103,003 were sold by Cobb Stuart on May 14 ’25. At $15.15 per share, Cobb Stuart sold 6,797 shares. The insider’s holdings dropped to 20,794 shares worth approximately $0.38 million following the completion of this transaction.
Also, STUART COBB purchased 6,797 shares, netting a total of over 105,421 in proceeds.
Before that, Cvijic Christine Mikail had sold 4,501 shares from its account. In a trade valued at $76,247, the President and CFO traded Neurogene Inc shares for $16.94 each. Upon closing the transaction, the insider’s holdings decreased to 4,501 shares, worth approximately $1.32 million.
As published in their initiating research note from Craig Hallum on June 17, 2025, Neurogene Inc [NGNE] has been a Buy and the price target has been revised to $50. Analysts at Robert W. Baird downgraded the stock from ‘”an Outperform”‘ to ‘”a Neutral”‘ outlook in a report released in mid May. As of June 27, 2024, BMO Capital Markets has initiated its “an Outperform” rating for NGNE. Earlier on June 11, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for NGNE stock.
Analyzing NGNE Stock Performance
On last trading session,, Neurogene Inc [NASDAQ: NGNE] plunged -0.65% to $18.30. The stock’s lowest price that day was $18.22, but it reached a high of $19.495 in the same session. During the last five days, there has been a drop of approximately -12.52%. Over the course of the year, Neurogene Inc shares have dropped approximately -19.95%. Shares of the company reached a 52-week high of $26.48 on 02/06/25 and a 52-week low of $6.88 on 04/08/25.
Support And Resistance Levels for Neurogene Inc (NGNE)
According to the 24-hour chart, there is a support level at 17.82, which, if violated, would cause prices to drop to 17.35. In the upper region, resistance lies at 19.17. The next price resistance is at 20.05. RSI (Relative Strength Index) is 48.80 on the 14-day chart, showing neutral technical sentiment.
Is Neurogene Inc subject to short interest?
Stocks of Neurogene Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.56 million shares to 2.39 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 2.95 million shares. A decline of -23.43% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 11.13 of the overall float, the days-to-cover ratio (short ratio) decline to 11.13.
Which companies own the most shares of Neurogene Inc (NGNE)?
In terms of Neurogene Inc share price expectations, FactSet research, analysts set an average price target of 38 in the next 12 months, up nearly 106.3% from the previous closing price of $18.42. Analysts anticipate Neurogene Inc stock to reach 50 by 2025, with the lowest price target being 16. In spite of this, 3 analysts ranked Neurogene Inc stock as Buy at the end of 2025. On April 29, 2024, Leerink Partners assigned a price target of “an Outperform” to the stock and initiated coverage with a $46.
